MSc Model-based Drug Development 12 months Postgraduate Program By The University of Manchester |Top Universities
Subject Ranking

# 25QS Subject Rankings

Program Duration

12 monthsProgram duration

Main Subject Area

Pharmacy and PharmacologyMain Subject Area

Program overview

Main Subject

Pharmacy and Pharmacology

Degree

MSc

Study Level

Masters

The MSc Model-based Drug Development course provides the knowledge and skills for making evidence-based decisions at various stages of drug development. It covers the scientific and regulatory aspects of evaluating a drug, with emphasis on the use of modelling and simulation methods. You will learn why these methods are so highly valued by industry and regulatory authorities as effective, cost-saving, decision-making tools. Learning is reinforced via application of modelling and simulation skills to real pharmacokinetic and pharmacodynamic data. The course has been developed with an emphasis on mechanistic approaches to assessing and predicting pharmacokinetics and pharmacodynamics (PKPD), such as physiologically-based pharmacokinetics (PBPK). This course is ideal for those wanting to apply their knowledge of modelling and simulation in various areas of research within the pharmaceutical industry. Full-time students benefit from immersion in the varied biomedical research environment at The University of Manchester, including interaction with research staff at the renowned Centre for Applied Pharmacokinetic Research . Alternatively, part-time students already working in the pharmaceutical industry can take advantage of the flexible, distance learning mode of the course.

Program overview

Main Subject

Pharmacy and Pharmacology

Degree

MSc

Study Level

Masters

The MSc Model-based Drug Development course provides the knowledge and skills for making evidence-based decisions at various stages of drug development. It covers the scientific and regulatory aspects of evaluating a drug, with emphasis on the use of modelling and simulation methods. You will learn why these methods are so highly valued by industry and regulatory authorities as effective, cost-saving, decision-making tools. Learning is reinforced via application of modelling and simulation skills to real pharmacokinetic and pharmacodynamic data. The course has been developed with an emphasis on mechanistic approaches to assessing and predicting pharmacokinetics and pharmacodynamics (PKPD), such as physiologically-based pharmacokinetics (PBPK). This course is ideal for those wanting to apply their knowledge of modelling and simulation in various areas of research within the pharmaceutical industry. Full-time students benefit from immersion in the varied biomedical research environment at The University of Manchester, including interaction with research staff at the renowned Centre for Applied Pharmacokinetic Research . Alternatively, part-time students already working in the pharmaceutical industry can take advantage of the flexible, distance learning mode of the course.

Admission Requirements

Jan-2000

Scholarships

Selecting the right scholarship can be a daunting process. With countless options available, students often find themselves overwhelmed and confused. The decision can be especially stressful for those facing financial constraints or pursuing specific academic or career goals.

To help students navigate this challenging process, we recommend the following articles:

More programs from the university

PhD Medicine arrows

Go to Programme ::type_cta_button::

PhD Physiology arrows

Go to Programme ::type_cta_button::

PhD Psychology arrows

Go to Programme ::type_cta_button::

PhD Materials arrows

Go to Programme ::type_cta_button::
Postgrad programs 389